Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
My doctor is considerate when making decisions and always loops me in
Instead of accepting their bodies, people may feel pressured to lose weight in a way that actually makes them less healthy
DESCRIPTION TABLE OF CONTENTS METHODOLOGY DOWNLOAD PDF Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035 USD 72.29 BN MARKET SIZE, 2035 BIOSIMILARS MARKET SIZE, SHARE & GROWTH SNAPSHOT Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis The global biosimilars market is projected to grow from USD 35.04 billion in 2025 to USD 72.29 billion by 2035, at a CAGR of 7.5% during the forecast period
Frequently Asked Questions What is the standard GHK-Cu injection dosage
US$ 25.56
US$ 23.40
US$ 20.55
